Table 2.
2.4‐Year Major Adverse Cardiovascular and Cerebrovascular Events According to Serum Uric Acid Tertiles in Patients With Different Numbers of SMuRFs
| No. SMuRFs | Group | Event, n (%) | Crude HR (95% CI) | Adjusted HR (95% CI) |
|---|---|---|---|---|
| 0–1 | Low uric acid | 63 (7.2) | 1 (reference) | 1 (reference) |
| Medium uric acid | 80 (10.2) | 1.444 (1.038–2.009)* | 1.478 (1.012–2.160)* | |
| High uric acid | 78 (12.6) | 1.359 (1.151–1.604)* | 1.469 (1.197–1.804)* | |
| Per 1 mg/dL increase | 221 (9.7) | 1.157 (1.056–1.269)* | 1.207 (1.082–1.347)* | |
| 2–3 | Low uric acid | 254 (11.4) | 1 (reference) | 1 (reference) |
| Medium uric acid | 259 (11.3) | 0.998 (0.840–1.187) | 0.957 (0.788–1.162) | |
| High uric acid | 317 (13.1) | 1.087 (1.000–1.180)* | 1.057 (0.958–1.167) | |
| Per 1 mg/dL increase | 830 (12.0) | 1.057 (1.008–1.132)* | 1.044 (0.988–1.104) | |
| 4 | Low uric acid | 57 (14.6) | 1 (reference) | 1 (reference) |
| Medium uric acid | 63 (15.0) | 1.038 (0.725–1.485) | 0.983 (0.665–1.453) | |
| High uric acid | 62 (13.7) | 0.972 (0.812–1.163) | 0.971 (0.795–1.185) | |
| Per 1 mg/dL increase | 182 (14.4) | 0.980 (0.888–1.082) | 0.979 (0.877–1.092) |
Adjusted for age, sex, body mass index, previous myocardial infarction, previous stroke, acute coronary syndrome, systolic blood pressure, triglyceride, low‐density lipoprotein cholesterol, minimum stent diameter, total stent length, and use of statin at discharge. HR indicates hazard ratio; and SMuRFs, standard modifiable cardiovascular risk factors.
*
P<0.05.